Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells

Abstract

The present data indicate that statins can inhibit the proliferation of receptor-positive and -negative human breast cancer cells but failed to completely abrogate the E(2)-induced proliferation of receptor-positive breast cancer cells. Clinical trials, however, are necessary to prove this anticarcinogenic action of statins.